Stepan Co. (SCL) Tops Q3 EPS by 40c
Tweet
Share
E-mailGet Alerts SCL Hot Sheet
Price: $65.28 --0%
Financial Fact:
Loss from equity in joint ventures: 0
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Loss from equity in joint ventures: 0
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Stepan Co. (NYSE: SCL) reported Q3 EPS of $2.01, $0.40 better than the analyst estimate of $1.61.
For earnings history and earnings-related data on Stepan Co. (SCL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
- Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
